Biodesix stock slumps on dimmer sales outlook
Biodesix Inc. saw its stock price slashed in early trading Friday after the life-sciences company that specializes in developing tools to detect lung disease lowered its 2026 sales forecast.
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Already have a paid subscription?


